AACR Special Conference on Tumor Immunology and Immunotherapy
in association with the AACR Cancer Immunology Working Group
October 1-4, 2023
The Westin Harbour Castle
Toronto, ON, Canada
Conference Cochairs:
Philip D. Greenberg, Fred Hutchinson Cancer Research Center, Seattle, Washington
Pamela S. Ohashi, UHN Princess Margaret Cancer Centre, Toronto, ON, Canada
Andrea Schietinger, Memorial Sloan Kettering Cancer Center, New York, New York
Mario Sznol, Yale University, New Haven, Connecticut
This AACR Special Conference on Tumor Immunology and Immunotherapy is designed to integrate multidisciplinary facets of basic cancer immunology and immunotherapy to broaden our understanding of ways to harness the immune system to treat cancer. The hallmark of this series is also to encourage the effective exchange of ideas between basic cancer immunologists, non-immunologists, and clinical oncologists in order to develop approaches that translate to outcomes. This year’s program will once again include a roster of international thought-leaders who will present and discuss new agent development, basic cancer immunobiology, engineering, target discovery, and translation of basic research to early clinical trial development. Speakers and participants will be encouraged to actively engage in panel discussions at the end of each session. The conference will begin with an opening keynote lecture from Dr. Crystal L. Mackall from Stanford University who will discuss T-cell engineering and CAR-T cell exhaustion. In addition to the keynote lecture and session topics noted above, two (2) poster sessions will be offered for attendees with abstracts accepted for presentation, with six (6) highly-rated abstracts to also be presented within thematically relevant plenary sessions. Plan to join colleagues and collaborators from around the world this October in Toronto.
AACR STATEMENT REGARDING VENUES FOR THE 2023 ANNUAL MEETING AND OTHER CONFERENCES
The AACR released a statement regarding the venues for the 2023 Annual Meeting and its other conferences in response to recent legislative and political decisions at the state level that may not align with our values.
Read the Statement View Program